BioSpace News Archive

21st China Hi-Tech Fair (CHTF2019) will be held on November 13-17, 2019

Aptevo Therapeutics Inc. (Nasdaq: APVO), a biotechnology company focused on developing novel oncology and hematology therapeutics, today provided a business review and reported its financial results for the third quarter ended September 30, 2019.

Rafael Pharmaceuticals Inc. (“Rafael” or the “Company”), a leader in the growing field of cancer metabolism-based therapeutics, announced today that it has joined the Scientific & Medical Affairs Industry Membership of the Pancreatic Cancer Action Network (“PanCAN”), a worldwide leader in the fight against pancreatic cancer.

The Company will announce its financial results for this period in a press release to be issued prior to the call.

Apixio Inc., the AI healthcare analytics company, today announced it has ranked number 227 on the Deloitte Technology Fast 500™, a list of the fastest-growing companies in North America.

The Pancreatic Cancer Action Network (PanCAN) announced today the official launch of its Pancreatic Cancer Awareness Month campaign, running throughout the month of November.

Except as described in this press release, all other terms of the tender offer as described in the Offer to Purchase, dated October 24, 2019, and the related Letter of Transmittal remain unchanged.

The Company intends to release its financial results and to file its 10-Q after the close of the market on November 14, 2019 followed by the conference call.

Agreements with commercialization partners support INVO Bioscience’s planned worldwide rollout of INVOcell

PulmOne USA Inc. has entered into a partnership agreement with Circassia Pharmaceuticals to offer the NIOX VERO® fractional exhaled nitric oxide (FeNO) airway inflammation measurement system as an integrated add-on to PulmOne’s MiniBox+.